HP Networking_ Configuring HP Networking IRF - Intelligent Resilient Framework (IRF)
The Importance of Neurorehabilitation in the Pursuit of ......Criteria for IRF/Acute Rehab...
Transcript of The Importance of Neurorehabilitation in the Pursuit of ......Criteria for IRF/Acute Rehab...
The Importance of
Neurorehabilitation in the Pursuit
of Neurovascular Excellence
SAMIR R. BELAGAJE, MD FAAN
OCTOBER 13, 2017
Disclosures
I have no commercial interests to disclose
Will discuss some off-label indications for medications such as SSRIs
Objectives
What are the 3 main ways a patient recovers from a stroke
What is neuroplasticity?
Name 3 meds which can be used to help with the recovery process
How does depression affect stroke recovery
Stroke in Perspective
Over 750,000 strokes per year
Fourth leading cause of death in U.S.
Leading cause of permanent disability
Cost exceeds $30 billion/year in U.S.
2/3 stroke survivors receive rehabilitation
The Traditional Model of
Stroke Care in the Hospital
Admission Evaluation/
Mgmt Disposition/D/C
Rehabilitation
Stroke Care is A Spectrum
Multiple phases with different specialists and goals of care
To optimize neurovascular excellence, must optimize care in each
phase
The Rehabilitation Phase
Recovery From Deficits Caused by Stroke
Adapting to Deficits Caused by Stroke
Usually More Chronic and usually the longest phase of stroke
Accomplished by Therapists, Rehabilitation specialists, but not
limited to them!
Caregiver involvement
Rehabilitation of Stroke: The Problem
• Compared to stroke onset, repair to brain cells takes much, much longer (days to
weeks to months…even years)
Repair and recovery is often incomplete
- 30% stroke survivors report some sort of activity restriction 4 years post-stroke
No proven ways to fix or replace brain tissue
People often plateau in their recovery
BOTTOM LINE: No proven guaranteed method
Future Model of Stroke Care in
The Hospital
Admission Evaluation
/Mgmt Disposition/D/C
Rehabilitation
Why Should We Care About
Rehabilitation in Stroke?
Ties Between the Phases
Improve Overall Outcomes in Patients
Medical Economics
Why Should We Care?- Medical
Economics
Reimbursement
- Changing Face of Medicine
Reduce complications
Affect Length of Stay
Adaptive
- Can be harmful (i.e. learned disuse)
Regeneration
- Preservation of penumbra
- Restitution of diaschisis
- Stem cells
* Rewiring (AKA Neuroplasticity)
Methods by Which The Brain
Recovers from A Stroke
Can be personal (learning to eat with another hand instead of using
hemiplegic hand)
Can involve assistive devices (e.g. cane, shower chair, prisms in
glasses for diplopia)
Learned disuse- can be maladaptive
- basis of constraint-induced therapy
Adaptation
Stem Cells, Growth factors
Shown to exist in adult brains of rats
- Migrate from subventricular zone in response to acute ischemic
injury to site of injury
- Multiply like crazy then die off
Application to humans is hot bed of research
Regeneration
Def. of Neuroplasticity-
Re-organization of nervous
system connections through
experience.
Conceptually-
Strengthening of previous
synapses, formation of new
ones, removal of others
Examples: Memory, Skill
learning (e.g. dribbling a
basketball), Phantom limb
pain
Neuroplasticity
Principles of Plasticity
Demand specific – Use it or Lose it
Task specific
Must be interesting or challenging enough for patient to attend to
Re-learning, not just increased activity
- e.g. in motor recovery, plasticity does not occur because of increased motor activity
After A Stroke…
Note: White Arrow denotes stroke location
Source: Feydy et. al. Stroke, 2002
1= Session 1-2 months post-
stroke
2= Session 2-4 months post-
stroke
3= Session 4-6 months post-
stroke
Source: Feydy et. al. Stroke, 2002
Neuroplasticity at the Molecular Level
Synapses in turn are determined by axonal and dendritic
sprouting
Factors:
* GAP43- linked to sprouting in cortex
* NogoA-inhibitor of axonal sprouting
* Other molecules (e.g. ECM proteins, Myelin-assoc
glycoprotein)
Implications for stroke recovery - All these molecules have been
identified in peri-infarct cortex (Carmichael et. al, 2002)
The Traditional Model of
Stroke Care in the Hospital
Admission Evaluation/
Mgmt Disposition/D/C
Rehabilitation
Following acute hospitalization, stroke survivors are usually sent to
3 different places:
- Home (with or without outpt therapy)
- Acute rehabilitation (AKA IRF AKA Acute rehab)
- Nursing home (AKA SNF AKA subacute rehab)
Acute rehab more intense therapy than SNF
Discharge Disposition-
Rehabilitation
Criteria for IRF/Acute Rehab
Admissions Need for 24 hour nursing care
Interdisciplinary team approach (documented team communication)
Discharge plan (Needs to able to return to community following IRF)
Multiple therapy disciplines (PT, OT and/or ST)
Intensive level of rehab (min. of 3 hours/day at least 5 days/week or in some cases an avg. of 15 hours per week if documented why)
Ability to participate in intensive rehab therapy & make measurable improvement
MD supervision on a daily basis
Outcome & Disposition
Source: Belagaje et. al. J Neurointerv Surg. 2014
Outcomes and Disposition
Only 1/22 (4.5%) patients who were discharged to SNF achieved a 90 day mRS ≤2, compared to 41/92 (44.6%) in the IRF group or 48/51 (94.1%) in the home group (p < 0.001).
For patients discharged with mRS=4, 1/14 (14.3%) showed improvement in SNF group compared to 21/27 (77.8%) in the IRF group (p=0.008). For discharge mRS =5, 5/14 (35.7%) showed improvement in the SNF group compared to 28/37 (75.7%) in the IRF group (p=0.013).
Source:
S. Belagaje, D.C Haussen, J. Saver, M. Goyal, D. Liebeskind, D. Yavagal, T. Jovin, R. Nogueira. The Impact of Post-acute discharge disposition on outcomes in the SWIFT PRIME Trial. Presented at ISC, AAN 2017
Stroke severity
Medical comorbidities
Socioeconomic
- Lack of Insurance
Inability to participate in therapy or tolerate therapy
Reasons Why Patients Don’t Qualify
for Acute Rehab Admissions
Infection-related Encephalopathies (UTIs, Pneumonias)
Toxic encephalopathies (Anxiolytics, Sedatives)
Alterations in sleep-wake cycle
Post-stroke seizures/post-ictal state
Post-stroke depression- (under Dx’ed, 20-40% incidence)
? Neurostimulation from Pharmacological treatment
Inability to participate in therapy
sessions-
Ilustrative Case....
80 year old female with cardioembolic stroke
On hospital day 2, she is evaluated by the therapy teams and found
to be lethargic and participating poorly in the therapy.
Because of her lethargy, the therapy team determines that she is
unable to participate in her three hours of therapy per day and
recommend SNF placement.
A subsequent evaluation by the primary team reveals that she has a
low grade fever, leukocytosis, and an urinalysis suggestive of an UTI.
With antibiotics, she improves over the next 2 days, better able to
participate in her therapy sessions and the discharge
recommendation is upgraded to an IRF.
Future Model of Stroke Care in
The Hospital
Admission Evaluation
/Mgmt Disposition/D/C
Rehabilitation
Medications for Rehabilitation
Can improve outcomes
Also worsen outcomes
Evidence remains mixed currently; no clear guidelines established
Pharmacological Goals:
Neurostimulation
Goal: Improve alertness and wakefulness
Amantadine
Methylphenidate
Goal: Address specific deficits
Memantine or Aricept for aphasia
Sources:
Liepert J. Update on pharmacotherapy for stroke and traumatic brain injury recovery during rehabilitation. Curr Opin Neurol. 2016 Dec;29(6):700-705.
Berthier ML, Pulvermüller F, Dávila G, Casares NG, Gutiérrez A. Drug therapy of post-
stroke aphasia: a review of current evidence. Neuropsychol Rev. 2011 Sep;21(3):302-17.
Pharmacological Goal: Remove or
Minimize The Harmful Meds (AKA The
“Bad Actors”
Benzodiazepines
Dopamine Antagonists
Opioids
Anticholinergics/Antihistaminergic Agents
Why Are These Medications Used In
the Stroke Unit?
Benzos Seizure treatment
Agitation/Delirium
Alcohol Withdrawal
Sleep
Opioids
Pain mgmt
Agitation
Headaches
Why Are These Medications Used In
the Stroke Unit?
Antipsychotic Agents
Agitation
ICU Psychosis
Antihistaminergic Agents
Sleep
GI prophylaxis
The Bad Actors
In some situations, use is indicated – would minimize dosing and stop
when ready
In other situations, use alternative pain meds
- Example: Pain mgmt
- Example: Use PPI instead of H2 blockers to minimize
antihistaminergic agents, particularly with elderly
Post-Stroke Depression
Prevalence = 33%; likely underdiagnosed
Can start at anytime post-stroke
Another study found prevalence to vary over time, peaking
at 3 to 6 months with a subsequent decline at 1 year
Difficult to diagnose- atypical Sx
- Reduced motivation, and loss of confidence
Effects on post-stroke outcomes
Depression has an adverse effect on post-stroke outcomes.
Severity of depression was directly correlated with level of physical, cognitive, and functional impairment.
Impairs the rehabilitation process with increased length-of-stays and slower
progress to rehabilitation goals.
Moreover, significant functional improvement at 3 and 6 months was noted in
stroke survivors with depression if it was reduced by 50%.
Earlier initiation of treatment is associated with the improvement on
outcome.
Antidepressant For Motor Improvement:
FLAME Trial
Chollet et. al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. The Lancet Neurology Vol. 10
(2), Feb 2011: 123-130.
Double-blind, placebo-controlled trial
Fluoxetine (20 mg once per day, orally) or placebo for 3 months starting 5-10
days after the onset of stroke
FLAME trial - Results
Upper extremity functional improvement at day 90 was significantly
greater in the fluoxetine group (adjusted mean 34·0 points [95% CI
29·7—38·4]) than in the placebo group (24·3 points [19·9—28·7];
p=0·003).
SSRI assisted motor recovery independent of its antidepressant
effect
Antidepressants: Implication for
Stroke Practice
Effect 1-2 weeks before effect noticed
Safety demonstrated in stroke and TBI patients
SSRIsbleeding risk
- Drug/drug interactions
Low threshold to start…safe and may even help motor outcomes or
generalized outcomes
Back to the Case….
80 yo F w/ cardioembolic stroke
While in the hospital, therapists report decreased participation in
their sessions and minimal gains. Recommend SNF
Nursing reports patient sleeping more
Family reports poor engagement and change in personality
Primary team suspects post-stroke depression and starts SSRI
After a Stroke…
Modified from: Fregni et. al. Nature Clinical Practice: Neurology,
2007
Other possibilities
Stem cells/trophic factors- studies underway
Stimulation
- Transcranial magnetic stimulation
- Transcranial Direct stimulation
Virtual Reality
Robotics
Stimulation TMS and TDCS
Hummel,
Cohen.
Lancet
Neurology
2006
Summary
What we know:
- Neuroplasticity seems to be the main way the brain recovers from a stroke
- Getting stroke patients who are unable to go home to acute rehab whenever possible
- Depression affects outcomes so important to look for it and treat it
Medications can affect rehabilitation
Future treatments: Stem cells and stimulation may be other interventional ways to help patients with strokes
Anyone involved in stroke care has a potential role to play in neurorehabilitation